BioSpace News Archive

Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company

Layoffs

Merck Abandons $1.3B R&D Center in London, Boots 125 Employees

Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.

September 11, 2025

·

1 min read

·

Tristan Manalac

Goal concept. Human hand in dotted pop art style pointing on the target for red paper plane. Vector illustration

Duchenne muscular dystrophy

Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA

Analysts at BMO Capital Markets expect the lack of other exon-44-skiping therapies to facilitate a “smooth” approval process for Avidity’s del-zota.

September 11, 2025

·

2 min read

·

Tristan Manalac

Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.

Gene therapy

Capsida Reports Patient Death in Gene Therapy Trial

Capsida has yet to disclose the exact cause of death. The patient had received the gene therapy CAP-002 for a type of epilepsy.

September 11, 2025

·

2 min read

·

Tristan Manalac

Photo of skyline of downtown New York, Brooklyn Bridge and Manhattan

Business

New York City’s Life Sciences Scene Grows in Stature

New York City has seen increased life sciences employment during the past decade as public funding and key projects like JLABS @ NYC have given the area a boost. A Partnership Fund for New York City executive discusses the city’s strengths and a notable challenge facing businesses.

September 11, 2025

·

5 min read

·

Angela Gabriel

Hiring collage showing HR checking applicant information

Job Trends

Hiring Outlook: Fewer Job Openings, High Competition Await Biopharma Job Seekers

The biopharma job market remains challenging, based on BioSpace data. In August, job postings live on the website dropped 32% year over year. In addition, during the first eight months of 2025, over 26,000 people were laid off or projected to be laid off.

September 11, 2025

·

4 min read

·

Angela Gabriel

U.S. and Chinese flags in concrete, broken in the middle

China

Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals

A draft executive order obtained by The New York Times purports to clamp down on the pharmaceutical industry’s ability to buy new molecules from biotechs based in China, along with a number of other proposed reforms.

September 11, 2025

·

2 min read

·

Dan Samorodnitsky